logo

Ardelyx, Inc (ARDX)



Trade ARDX now with
  Date
  Headline
12/11/2017 6:02:02 AM Ardelyx Enters License Agreement With Shanghai Fosun Pharmaceutical Industrial Development For Tenapanor In China
11/28/2017 1:38:49 PM Wedbush Is Raising Ardelyx, Inc (ARDX) FY18 Estimate To -0.88 From -1.31
11/28/2017 1:38:30 PM Wedbush Is Raising Ardelyx, Inc (ARDX) Q4 18 Estimate To -0.24 From -0.31
11/28/2017 1:38:12 PM Wedbush Is Raising Ardelyx, Inc (ARDX) Q3 18 Estimate To -0.23 From -0.35
11/28/2017 1:37:57 PM Wedbush Is Increasing Ardelyx, Inc (ARDX) Q2 18 Estimate To -0.21 From -0.33
11/28/2017 1:37:37 PM Wedbush Is Increasing Ardelyx, Inc (ARDX) Q1 18 Estimate To -0.20 From -0.32
11/28/2017 1:37:19 PM Wedbush Is Raising Ardelyx, Inc (ARDX) FY17 Estimate To -1.88 From -2.01
11/28/2017 1:37:05 PM Wedbush Is Raising Ardelyx, Inc (ARDX) Q4 17 Estimate To -0.31 From -0.44
11/28/2017 1:36:39 PM Wedbush Reiterates Ardelyx, Inc (ARDX) At Outperform With $13 Up From $12 Price Target
11/28/2017 2:01:38 AM Ardelyx And Kyowa Hakko Kirin Enter License Agreement For Tenapanor For Cardiorenal Diseases In Japan
11/22/2017 6:18:42 AM Wedbush Reiterates Ardelyx, Inc (ARDX) At Outperform With $12 Down From $16 Price Target
11/22/2017 6:17:54 AM Wedbush Is Increasing Ardelyx, Inc (ARDX) 2018 Estimate To -1.31 From -1.75
11/7/2017 11:52:07 AM Wedbush Is Increasing Ardelyx, Inc (ARDX) 2018 Estimate To -1.75 From -2.02
11/7/2017 11:51:55 AM Wedbush Is Raising Ardelyx, Inc (ARDX) 4Q18 Estimate To -0.42 From -0.48
11/7/2017 11:51:19 AM Wedbush Is Raising Ardelyx, Inc (ARDX) 3Q18 Estimate To -0.47 From -0.54
11/7/2017 11:50:59 AM Wedbush Is Raising Ardelyx, Inc (ARDX) 2Q18 Estimate To -0.45 From -0.51
11/7/2017 11:50:43 AM Wedbush Is Raising Ardelyx, Inc (ARDX) 1Q18 Estimate To -0.42 From -0.49
11/7/2017 11:50:29 AM Wedbush Is Raising Ardelyx, Inc (ARDX) FY18 Estimate To -1.75 From -2.02